Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163488
Status:
COMPLETED
Last Update Posted:
2016-12-05
First Post:
2005-09-12
Brief Title:
Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone DipropionateSalmeterol in Adults With Perennial Allergic Rhinitis BY9010M1-409
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Fluticasone PropionateSalmeterol FPSAL in Patients 18-60 Years With Perennial Allergic Rhinitis PAR
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of combined ciclesonide nasal spray administered along with a fixed combination of inhaled fluticasone dipropionatesalmeterol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None